Cutaneous chronic graft-versus-host disease reduces quality of life through skin symptoms and broader impacts, guiding ...

In the 132-patient ROCKstar study, almost three quarters of chronic GVHD patients treated with a daily oral dose of belumosudil (KD025) saw an improvement in symptoms that lasted for at least six ...

The regulator has cleared Ryoncil (remestemcel-L) to treat steroid-refractory acute GVHD in paediatric patients aged two months and older. It is derived from MSCs harvested from the bone marrow of ...

A YOUNG mum battling a rare form of cancer passed away surrounded by loved ones after suffering complications from treatment.

The diagnosis of most of these complications can ... transfusion-associated graft-versus-host disease (TA-GVHD), post-transfusion purpura (PTP) and anaphylactic reactions because of IgA in plasma ...

Dupixent® is now used to treat over a million patients globally, with continued growth and expansion in multiple indications for diseases in ...